Occurrence of Community-Acquired Respiratory Tract Infection in Patients Receiving Esomeprazole: Retrospective Analysis of Adverse Events in 31 Clinical Trials

Author： Estborn Lennart   Joelson Svante  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.31, Iss.7, 2008-01, pp. : 627-636

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gatifloxacin in community-acquired respiratory tract infection

By Sethi Sanjay  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 10, 2003-10 ,pp. : 1847-1855

Informa Healthcare

Access to resources Recommend Favorite

Moxifloxacin: A Review of its Clinical Potential in the Management of Community-Acquired Respiratory Tract Infections

By Barman Balfour J.A.   Lamb H.M.  

Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. : 115-139

Adis International

Access to resources Recommend Favorite

Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycin

By Nicolau David P  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 229-235

Informa Healthcare

Access to resources Recommend Favorite

Clarithromycin extended-release in community-acquired respiratory tract infections

By Williams Kathy N   Bishai William R  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2867-2876

Informa Healthcare

Access to resources Recommend Favorite

Generic versus Non-Generic Formulation of Extended-Release Clarithromycin in Patients with Community-Acquired Respiratory Tract Infections: A Prospective, Randomized, Comparative, Investigator-Blind, Multicentre Study

By Snyman J.R.  

Clinical Drug Investigation, Vol. 29, Iss. 4, 2009-01 ,pp. : 265-274

Adis International

Access to resources Recommend Favorite